Literature DB >> 3099567

Primary sclerosing cholangitis in the presence of a lupus anticoagulant.

D F Kirby, A T Blei, S T Rosen, R L Vogelzang, H L Neiman.   

Abstract

Lupus anticoagulant, an immunoglobulin that prolongs the partial thromboplastin time, has been associated with thrombotic events, including deep venous thrombosis, pulmonary emboli, and Budd-Chiari syndrome. In this report, primary sclerosing cholangitis was diagnosed in a man with a 10-year history of multiple thrombotic events related to a circulating lupus anticoagulant. Progressive jaundice and pruritus developed, and sclerosing cholangitis was confirmed by direct cholangiography. Sclerosing cholangitis is the second hepatobiliary disease reported in association with a lupus anticoagulant.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3099567     DOI: 10.1016/0002-9343(86)90412-2

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

1.  Primary sclerosing cholangitis associated with lupus nephritis: a rare association.

Authors:  Yoshiko Kadokawa; Katsuhisa Omagari; Isao Matsuo; Yoshiko Otsu; Umpei Yamamoto; Tomoya Nishino; Kazuo Ohba; Masanobu Miyazaki; Takashi Harada; Takashi Taguchi; Shigeru Kohno
Journal:  Dig Dis Sci       Date:  2003-05       Impact factor: 3.199

2.  Anticoagulation therapy may reverse biliary abnormalities due to acute portal thrombosis.

Authors:  Alexandre Louvet; Frederic Texier; Sebastien Dharancy; François-Rene Pruvot; Geraldine Sergent; Pierre Deltenre; Olivier Ernst; Jean-Claude Paris; Philippe Mathurin
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

Review 3.  Autoantibodies in primary sclerosing cholangitis.

Authors:  Johannes-Roksund Hov; Kirsten-Muri Boberg; Tom-H Karlsen
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

4.  Anti-cardiolipin antibodies in ischaemic heart disease.

Authors:  P Klemp; R C Cooper; F J Strauss; E R Jordaan; J Z Przybojewski; N Nel
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

5.  Trigger mechanisms of secondary sclerosing cholangitis in critically ill patients.

Authors:  Silke Leonhardt; Wilfried Veltzke-Schlieker; Andreas Adler; Eckart Schott; Roland Hetzer; Walter Schaffartzik; Michael Tryba; Peter Neuhaus; Daniel Seehofer
Journal:  Crit Care       Date:  2015-03-31       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.